Evolus Inc. Common Stock. Replay the stock market charts of EOLS day by day back to 2003. Open long and short positions without spending any money. Evolus Inc is engaged in providing physicians and their patients with expanded choices in medical aesthetic treatments and procedures. Its product candidate is an injectable formulation of a 900 kDa Botulinum toxin Type A complex.
